Thursday, February 6, 2025
HomeHealth ConditionsME/CFSImmunologic Component of Chronic Fatigue Syndrome

Immunologic Component of Chronic Fatigue Syndrome

Myalgic encephalomyelitis, or chronic fatigue syndrome, is a condition with unknown causation. In 2017, a group of researchers led by Jose Montoya did a study to determine if there is an immunologic component to the severity and duration of symptoms experienced by patients affected with this condition.

Myalgic encephalomyelitis, or chronic fatigue syndrome, is a condition with unknown cause characterized as having persistent unexplained fatigue of at least six months which impairs activities of daily living.

In an article published in the Proceedings of the National Academy of Sciences of the United States of America (PNAS) Journal this 2017, a group of researchers led by Jose Montoya conducted a study to explore the association of different cytokines in the disease severity and duration of myalgic encephalomyelitis. Cytokines are cells secreted by the body’s immune system which can have different effects on other cells. Cytokines from 186 patients diagnosed with myalgic encephalomyelitis and 388 healthy controls were gathered by collecting blood specimens and analyzed using a cytokine assay.

The study found that 17 different cytokines were more elevated in patients who were diagnosed with myalgic encephalomyelitis. Of these 17 cytokines, 13 were found to be pro-inflammatory, which may contribute to the symptoms experienced by patients affected with myalgic encephalomyelitis. Transforming growth factor β, a protein which has a role in cell growth and proliferation was also found to be elevated in this group.

Overall, the findings of the study suggest that myalgic encephalomyelitis has a strong immunologic component. Further research addressing this component can be done to improve the clinical management and outcome of this condition.

Written by Karla Sevilla

Reference: Montoya, J., et al. (2017). Cytokine signature associated with disease severity in chronic fatigue syndrome. PNAS. doi: 10.1073/pnas.1710519114

Add to Flipboard Magazine.

RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest News and Articles

SUBSCRIBE TO OUR NEWSLETTERS

Stay Connected
10,288FansLike
820FollowersFollow
249FollowersFollow
2,787FollowersFollow

Article of the month

Weight loss drug Tirzepatide helps beat heart failure

New drug, tirzepatide, shows promise for patients with diastolic/preserved ejection fraction heart failure. Find out more with MNB.

Joke Of The Day – February 6

- Doctor, can you come to our house right now? - What happened? - We cannot get inside of our house. - Then you should call the...

ADVERTISE WITH US

error: Content is read-only and copy-protected.